John E. Landers

15.6k citations

53 papers · 2.6k indexed · 1 hit paper · h-index 33

Neurology top 1%
- Amyotrophic Lateral Sclerosis Research 32
- Parkinson's Disease Mechanisms and Treatments 8
Genetics top 1%
- Neurogenetic and Muscular Disorders Research 26
Neurology top 5%
- Amyotrophic Lateral Sclerosis Research 32
- Parkinson's Disease Mechanisms and Treatments 8
Molecular Biology top 5%
- RNA Research and Splicing 9
- Prion Diseases and Protein Misfolding 5
- RNA modifications and cancer 4
Cell Biology top 5%
Cellular and Molecular Neuroscience
- Genetic Neurodegenerative Diseases 5
Oncology
- Cancer-related Molecular Pathways 5

Co-authors: Donna L. George Robert H. Brown Linda J. Engle Daryl A. Bosco Peter C. Sapp Pamela Keagle Vincenzo Silani Dale S. Haines
Cited by: Neurology Genetics
Journals: Neurology (5 papers)Proceedings of the National Academy of Sciences (5 papers)Neurobiology of Aging (4 papers)
Partner nations: United States Italy United Kingdom

In The Last Decade

John E. Landers

53 papers receiving 2.6k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by John E. Landers

Since Specialization

Citations

This map shows the geographic impact of John E. Landers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Landers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Landers more than expected).

Fields of papers citing papers by John E. Landers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John E. Landers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Landers. The network helps show where John E. Landers may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John E. Landers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John E. Landers Line = papers co-authored together John E. Landers links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Loss of function of the ALS-associated NEK1 kinase disrupts microtubule homeostasis and nuclear import Science Advances ·Jacob R. Mann,Fjodor Gerenok,Catherine A. Hartford,Verônica Letícia Magalhães da Silva,Francesco Alessandrini,Eric N. Anderson,R.M. Mayers,Yuji MORITA,Tsang Hs,Ihor Yakymyshyn,Desiree M. Baron,Amy Profitt,John E. Landers,Udai Bhan Pandey,Evangelos Kiskinis	2023	18
2	Amyotrophic lateral sclerosis: translating genetic discoveries into therapiesbreakdown → Nature Reviews Genetics ·Fulya Akçimen,Gao Yu-jing,John E. Landers,Avindra Nath,Adriano Chiò,Ruth Chia,Bryan J. Traynor	2023	103
3	Homozygous might be hemizygous: CRISPR/Cas9 editing in iPSCs results in detrimental on-target defects that escape standard quality controls Stem Cell Reports ·Dina Simkin,Verônica Letícia Magalhães da Silva,Bernabé I. Bustos,Christina M. Ambrosi,Steven J. Ryan,Valeriya Baru,Luis A. Williams,Graham T. Dempsey,Owen B. McManus,John E. Landers,Steven Lubbe,Alfred L. George,Evangelos Kiskinis	2022	36
4	Interactions between ALS-linked FUS and nucleoporins are associated with defects in the nucleocytoplasmic transport pathway Nature Neuroscience ·Yen‐Chen Lin,Ali Abdi Yusuf,Nandini Ramesh,Eric N. Anderson,Aivi T. Nguyen,Khuong A. Tran,Simon Cheung,Justin A. McDonough,William C. Skarnes,(unknown),John E. Landers,Nicolas L. Fawzi,Ian R. Mackenzie,Edward B. Lee,Jeffrey A. Nickerson,David Grünwald,Udai Bhan Pandey,Daryl A. Bosco	2021	63
5	Modulation of actin polymerization affects nucleocytoplasmic transport in multiple forms of amyotrophic lateral sclerosis Nature Communications ·Astrid Ekelmans,Eric Danielson,Valentina Gumina,Daniela Ferreira Fava,Sivakumar Boopathy,Robert H. Brown,Antonia Ratti,John E. Landers,Claudia Fallini	2019	54
6	TDP-43 and NOVA-1 RNA-binding proteins as competitive splicing regulators of the schizophrenia-associated TNIK gene Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms ·Valentina Gumina,Claudia Colombrita,Claudia Fallini,Patrizia Bossolasco,Alena S Gorbenkova,John E. Landers,Vincenzo Silani,Antonia Ratti	2019	16
7	The LRRK2 Variant E193K Prevents Mitochondrial Fission Upon MPP+ Treatment by Altering LRRK2 Binding to DRP1 Frontiers in Molecular Neuroscience ·María Dolores Pérez‐Carrión,Francesca Pischedda,Alice Biosa,Isabella Russo,Letizia Straniero,Laura Civiero,Marianna Guida,Christian Johannes Gloeckner,Nicola Ticozzi,Cinzia Tiloca,Claudio Mariani,Gianni Pezzoli,Stefano Duga,Irene Pichler,Lifeng Pan,John E. Landers,Elisa Greggio,Michael W. Hess,Stefano Goldwurm,Giovanni Piccoli	2018	32
8	ALS-linked FUS exerts a gain of toxic function involving aberrant p38 MAPK activation Scientific Reports ·Reddy Ranjith K. Sama,Claudia Fallini,Rodolfo G. Gatto,Katja Ihamäki,Yuyu Song,Melissa Rotunno,J. E. BENSON,Charity M. Lander,John E. Landers,Gerardo Morfini,Scott T. Brady,Daryl A. Bosco	2017	47
9	A Drosophila model of ALS reveals a partial loss of function of causative human PFN1 mutants Human Molecular Genetics ·Jean-François Ruys,Astrid Ekelmans,Hélène Tran,Claudia Fallini,Fen‐Biao Gao,John E. Landers	2017	11
10	Novel mutations support a role for Profilin 1 in the pathogenesis of ALS Neurobiology of Aging ·Bradley Smith,Caroline Vance,Emma L. Scotter,Claire Troakes,Chun Hao Wong,Simon Topp,Satomi Maekawa,Andrew King,Jacqueline C. Mitchell,张翠玉,Ammar Al‐Chalabi,Nicola Ticozzi,Vincenzo Silani,Peter C. Sapp,Robert H. Brown,John E. Landers,Safa Al‐Sarraj,Christopher E. Shaw	2014	81
11	A loss of FUS/TLS function leads to impaired cellular proliferation Cell Death and Disease ·Catherine L. Ward,Weigl Engelhard,CESAR IZZO SANDER,Justin D. Boyd,順利周,Scott A. Shaffer,John E. Landers,Marcie A. Glicksman,Daryl A. Bosco	2014	41
12	Ribonuclease 4 protects neuron degeneration by promoting angiogenesis, neurogenesis, and neuronal survival under stress Angiogenesis ·Shuping Li,Jinghao Sheng,Jamie K. Hu,Wenhao Yu,Hiroko Kishikawa,Miaofen G. Hu,Kaori Shima,David M. Wu,Zhengping Xu,Winnie Xin,Katherine B. Sims,John E. Landers,Robert H. Brown,Guo-fu Hu	2012	47
13	Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosis American Journal of Medical Genetics Part B Neuropsychiatric Genetics ·Nicola Ticozzi,Caroline Vance,Aurélie Leclerc,Pamela Keagle,Jonathan D. Glass,D. McKenna‐Yasek,Peter C. Sapp,Vincenzo Silani,Daryl A. Bosco,Christopher E. Shaw,Robert H. Brown,John E. Landers	2011	136
14	Mutational analysis of TARDBP in neurodegenerative diseases Neurobiology of Aging ·Nicola Ticozzi,Ashley LeClerc,Marka van Blitterswijk,Pamela Keagle,Diane McKenna‐Yasek,Peter C. Sapp,Vincenzo Silani,Anne‐Marie Wills,Robert H. Brown,John E. Landers	2009	52
15	The Role of Copy Number Variation in Susceptibility to Amyotrophic Lateral Sclerosis: Genome-Wide Association Study and Comparison with Published Loci PLoS ONE ·Louise V. Wain,Inti Pedroso,John E. Landers,Gerome Breen,Christopher E. Shaw,P. Nigel Leigh,Robert H. Brown,Martin D. Tobin,Ammar Al‐Chalabi	2009	37
16	DNA sequence analysis of the conserved region around the SOD1 gene locus in recessively inherited ALS Neuroscience Letters ·Wendy Broom,Fullerton Leonard Waldo,Manuel Garber,Peter M. Andersen,Niall J. Lennon,John E. Landers,Chad Nusbaum,Carsten Russ,Robert H. Brown	2009	6
17	Using high-throughput SNP technologies to study cancer Oncogene ·Linda J. Engle,Claire L. Simpson,John E. Landers	2006	93
18	Genome complexity reduction for SNP genotyping analysis Proceedings of the National Academy of Sciences ·龚声武,Alain Charest,John Dowd,Justin P. Blumenstiel,Ru‐Fang Yeh,Asiah Osman,David E. Housman,John E. Landers	2002	30
19	Functional characterization of ORCTL2 ‐ an organic cation transporter expressed in the renal proximal tubules FEBS Letters ·Wesley Voshell,Dirk Prawitt,John E. Landers,Christina Kast,Piet Gros,David E. Housman,Bernhard Zabel,Jerry Pelletier	1998	24
20	Expression patterns of the p53 tumor suppressor gene and the mdm2 proto-oncogene in human meningiomas Journal of Neuro-Oncology ·Mark Pykett,John E. Landers,Donna L. George	1997	14

About John E. Landers

John E. Landers is a scholar working on Genetics, Neurology and Aging, having authored 53 papers that have together received 2.6k indexed citations. Recurring topics across this work include Amyotrophic Lateral Sclerosis Research (32 papers), Neurogenetic and Muscular Disorders Research (26 papers), RNA Research and Splicing (9 papers), Parkinson's Disease Mechanisms and Treatments (8 papers), Prion Diseases and Protein Misfolding (5 papers), Genetic Neurodegenerative Diseases (5 papers), Cancer-related Molecular Pathways (5 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Neurology (1.2k citations), Genetics (711 citations) and Neurology (269 citations). John E. Landers has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Donna L. George, Robert H. Brown, Linda J. Engle, Daryl A. Bosco, Peter C. Sapp, Pamela Keagle, Vincenzo Silani, Dale S. Haines, Nicola Ticozzi and Marka van Blitterswijk. Their work appears in journals such as Neurology, Proceedings of the National Academy of Sciences, Neurobiology of Aging, Human Molecular Genetics and Science Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact